"Designing Growth Strategies is in our DNA"

Neurodegenerative Diseases Drugs Market Size, Share and Industry Analysis By Drug Class (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), By Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA), Others), By Route of Administration (Oral, Injection, Transdermal, Others), By End User and Regional Forecast 2019-2026

The global neurodegenerative diseases drugs market size was valued at USD 35,497.3 Million in 2018, is projected to reach USD 62,786.2 Million by the end of 2026, exhibit... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Jun, 2019 | Report ID: FBI100661 | Status : Published

 

Speak to Analyst

Refresh Button
Neurodegenerative Diseases Drugs Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 166
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X